Edition:
United Kingdom

Celcuity Inc (CELC.OQ)

CELC.OQ on NASDAQ Stock Exchange Capital Market

18.78USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$18.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$21.65
52-wk Low
$11.10

Chart for

About

Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living... (more)

Overall

Beta: --
Market Cap(Mil.): $126.97
Shares Outstanding(Mil.): 9.72
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Celcuity reports Q3 loss $0.26/shr

* Celcuity reports third quarter fiscal 2017 financial results

13 Nov 2017

BRIEF-Celcuity announces pricing of initial public offering

* Celcuity Llc - ‍announced today pricing of its upsized IPO of 2,400,000 shares of its common stock at a public offering price of $9.50 per share​

20 Sep 2017

Earnings vs. Estimates